ChemDiv, a global contract research organization has signed a collaborative discovery research agreement with Siwa Biotech, located in Oklahoma City, Oklahoma.
Subscribe to our email newsletter
Under the agreement, ChemDiv will be initiating a high-throughput screen for small molecule inhibitors of tyrosylprotein sulfotransferases. The collaboration provides Siwa Biotech with access to ChemDiv’s expertise in chemistry systems and lead discovery.
Kevin Moore, president of Siwa Biotech, said: “We are excited to initiate this collaborative discovery project with ChemDiv. The project has an excellent chance of success, based on ChemDiv’s excellent track record in small molecule drug discovery.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.